Development of α ‐Tocopherol Loaded PLGA Nanoparticles and Its Evaluation as a Novel Immune Adjuvant
Macromolecular Rapid Communications · 2025
DOI: 10.1002/marc.202400400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Rapid Communications, 2025. Verfasst von Huan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Multiphase Materials Chemical Engineering, Department of Product Engineering, School of Chemical Engineering, East China U…. Hauptthemen laut MEDLINE: alpha-Tocopherol, Nanoparticles, Polylactic Acid-Polyglycolic Acid Copolymer, Adjuvants, Immunologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
With the continuous development of preventive and therapeutic vaccines, traditional adjuvants cannot provide sufficient immune efficacy and it is of high necessity to develop safe and effective novel nanoparticle‐based vaccine adjuvants. α ‐Tocopherol (TOC) is commonly used in oil‐emulsion adjuvant systems as an immune enhancer, yet its bioavailability is limited by poor water solubility. This study aims to develop TOC‐loaded poly(lactic‐ co ‐glycolic acid) (PLGA) nanoparticles (TOC‐PLGA NPs) to explore the potential of TOC‐PLGA NPs as a novel nanoparticle‐immune adjuvant. TOC‐PLGA NPs are prepared by a nanoprecipitation method and their physicochemical properties are characterized. It is shown that TOC‐PLGA NPs are 110.8 nm, polydispersity index value of 0.042, and Zeta potential of −13.26 mV. The encapsulation efficiency and drug loading of NPs are 82.57% and 11.80%, respectively, and the cumulative release after 35 days of in vitro testing reaches 47%. Furthermore, TOC‐PLGA NPs demonstrate a superior promotion effect on RAW 264.7 cell proliferation compared to PLGA NPs, being well phagocytosed and also promoting antigen uptake by macrophages. TOC‐PLGA NPs can strongly upregulate the expression of co‐stimulatory surface molecules and the secretion of cytokines. In conclusion, TOC‐PLGA NPs can be a novel vaccine adjuvant with excellent biocompatibility and significant immune‐enhancing activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Multiphase Materials Chemical Engineering, Department of Product Engineering, School of Chemical Engineering, East China University of Science and Technology, No.130 Mei Long Road, Shanghai, 2…
- Shanghai Mingqi Energy Technology Co., Ltd, No. 29, Lane 155, Baocheng Road, Shanghai, 201199, China.
ORCID-Profile: Lian Cen
Zitieren
APA
Zhang, H., Song, M., Zhuang, S., Wang, Z., Shi, H., Song, Z., Song, C., & Cen, L. (2025). Development of α ‐Tocopherol Loaded PLGA Nanoparticles and Its Evaluation as a Novel Immune Adjuvant. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202400400
Vancouver
Zhang H, Song M, Zhuang S, Wang Z, Shi H, Song Z, et al. Development of α ‐Tocopherol Loaded PLGA Nanoparticles and Its Evaluation as a Novel Immune Adjuvant. Macromolecular Rapid Communications. 2025. doi:10.1002/marc.202400400
BibTeX
@article{Zhang2025,
author = {Zhang, Huan and Song, Meng and Zhuang, Shiya and Wang, Zining and Shi, Hui and Song, Zhuolang and Song, Chuanhe and Cen, Lian},
title = {Development of α ‐Tocopherol Loaded PLGA Nanoparticles and Its Evaluation as a Novel Immune Adjuvant},
journal = {Macromolecular Rapid Communications},
year = {2025},
doi = {10.1002/marc.202400400}
}
EUVIMED